About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

Convalescent Plasma for Severe COVID-19 Patients | Clinical Trials | Clareo Health

COMPLETEDPhase 3

Convalescent Plasma for Severe COVID-19 Patients

Convalescent Plasma for Severe COVID-19 Patients: a Randomized, Open-label, Phase 3 Trial

NCT04547660•Hospital de Clinicas de Porto Alegre

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Covid19

Interventions

Convalescent Plasma

Best Supportive Care

Locations

1

Brazil

Locations (1)

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Key Dates

Start Date

July 16, 2020

Primary Completion Date

January 7, 2021

Completion Date

January 7, 2021

Last Updated

February 9, 2021

Related Studies

The Effect of the Covid-19 Pandemic Among Operated Patients

NCT04525716

RECRUITINGPhase 3

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

NCT03188796

Critical IllnessVitamin D Deficiency+1 more

RECRUITINGPhase 1

Covid-19 and Influenza Oral Vaccine Study

NCT06355232

covid19 InfectionInfluenza, Human

Conversations You Want About Corona Virus Disease (COVID-19)

NCT05191420

Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19

NCT04611243

Lung FunctionExercise Capacity+2 more

COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy

NCT04678193

View all related studies

Sponsors

Lead Sponsor

Hospital de Clinicas de Porto Alegre

Collaborators

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
Instituto Cultural Floresta

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 9, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions